Clover Health Investments, Corp.: interim CFO Thornton Clay sold 4,591 shares

What happened

• Thornton Clay, interim CFO, sold 4,591 shares of Class A common stock on Oct 15, 2026, at a weighted average price of $4.68 for total proceeds of $21,486.

Key details

• Transaction date and price: Oct 15, 2026; weighted average price $4.68 (range $4.67 to $4.68).
• Shares sold and value: 4,591 shares for $21,486.
• Shares owned after the transaction: not reported in the provided filing.
• Footnotes: the filing says the sales were required to cover tax withholding on the vesting of 6.25% of restricted stock units that vested on Oct 15, 2026 (RSUs originally granted Oct 15, 2024). The remaining RSUs vest quarterly in equal 6.25% installments, with final vesting on Oct 15, 2028. The filing says the sales were mandated by the issuer's "sell to cover" election and do not represent discretionary trades. The filing also notes the reported price is a weighted average and the reporting person can provide a breakdown of individual sale prices on request.
• Form 4 file date: Oct 19, 2026 (period of report Oct 15, 2026). The filing does not indicate a late-filing code in the provided information.

Why it may matter

• The filing says these were sales to satisfy tax withholding for RSU vesting (a sell-to-cover), not voluntary, discretionary sales by the reporting person.
• A filing does not show why the insider traded or why the company acted.